#pharmaceutical-research
#pharmaceutical-research

[ follow ]

Federal Circuit Reverses Injunction Against Avadel Due to Hatch-Waxman Safe Harbor

Federal Circuit overturned injunction, allowing Avadel to conduct pre-approval activities for Lumryz under Hatch-Waxman 'safe harbor'.

AI has the potential to greatly enhance the drug discovery process by addressing the challenges of cost and time.

[ Load more ]